QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor
المؤلف | Danjuma, Mohammed I. |
المؤلف | Sinha, Urshita |
المؤلف | Fatima, Haajra |
المؤلف | Mohamed, Mouhand F.H. |
المؤلف | Nathoe, Hendrik |
تاريخ الإتاحة | 2024-02-14T11:20:46Z |
تاريخ النشر | 2020-09-12 |
اسم المنشور | European Journal of Clinical Investigation |
المعرّف | http://dx.doi.org/10.1111/eci.13407 |
الاقتباس | Danjuma, M. I., Sinha, U., Fatima, H., Mohamed, M. F., & Nathoe, H. (2021). QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor. |
الرقم المعياري الدولي للكتاب | 0014-2972 |
الملخص | We read with interest Monzani et al's report1 on QT pro-longation in COVID-19 patients on treatment with chloro-quine/hydroxychloroquine (CQ/HCQ). Her report highlights the therapeutic morbidities that have unfortunately evolved as part of the measures to control COVID-19 pandemic. Cardiac toxicity including QTc prolongation has been well established as part of the syndrome of adverse events associated with CQ/HCQ administration.2 Since the advent of the COVID-19 pandemic, there has been increasing reports of various phe-notypes of QTc prolongation and its sequelae in COVID-19 patients on treatment with CQ/HCQ. |
اللغة | en |
الناشر | Wiley-Blackwell |
الموضوع | QTc interval COVID-19 |
النوع | Other |
رقم العدد | 11 |
رقم المجلد | 50 |
ESSN | 1365-2362 |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث فيروس كورونا المستجد (كوفيد-19) [809 items ]
-
أبحاث الطب [1413 items ]